Clinical Trials
10 trialsNCT07552558 2026-06-03
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Washington University School of Medicine
Phase 1/2 Not yet recruiting
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT05837221 2026-02-24
Microbiome in Head and Neck Squamous Cell Carcinoma
University of Colorado, Denver
Recruiting
NCT03174275 2026-02-23
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT00568490 2025-07-02
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University
Recruiting
NCT07005115 2025-06-06
Serum Lipid Profile and Lip Squamous Cell Carcinoma
Akdeniz University
Completed
NCT03422536 2024-09-04
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
University of Arizona
Phase 2 Completed
NCT05610293 2023-08-16
T1 Squamous Cell Carcinomas of the Lip
Maastricht University Medical Center
Unknown
NCT01084733 2021-07-14
Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
University of Kentucky
Completed
NCT00186433 2015-05-27
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Stanford University
Completed